MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-09-0008840
Elinor Pharmaceuticals Private Limited - pharma in Hyderabad, Andhra Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹12.99 Cr
▼ 30% YoY
Net profit · FY 2024
₹33.24 Lakh
Net margin 2.6%
EBITDA · FY 2024
₹74.99 Lakh
EBITDA margin 5.8%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹36 Lakh
Issued & subscribed
Company age
16 yrs
Est. 2010
Employees · EPFO
89
Provident fund records
Directors on board
2
As per MCA filings
About Elinor Pharmaceuticals Private Limited
Data last updated:
Elinor Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Andhra Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 19 November 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2010PTC071273. Its GSTIN is 36AACCE5699Q1ZP (Telangana). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹36 Lakh. It is led by directors Gopala Krishna Konduru and Salla Santosh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at #2 – 4 – 602 Road No.9/A Behind Andhra Bank Nagole, Hyderabad, Andhra Pradesh, India – 500035.
As per the financials filed for FY 2024, the company reported a revenue of ₹12.99 Cr, a decline of 30% compared to the previous year. For the same year it recorded a net profit of ₹33.24 Lakh (net margin 2.6%) and EBITDA of ₹74.99 Lakh (EBITDA margin 5.8%). Revenue has declined at a compounded annual rate (CAGR) of 5% over three years and 2% over five years.
The company has about 89 employees on its provident fund (EPFO) records.
Court records list 12 cases involving the company, including 12 filed by the company; 9 cases are pending.
Elinor Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-09-0008840). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website elinorpharma.wordpress.com.
Company details
CIN U24232TG2010PTC071273
Registration Number 071273
Incorporation Date 19 November 2010
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-09-0008840
CIN history
Elinor Pharmaceuticals has one previous CIN (Corporate Identification Number): U24232AP2010PTC071273. The current CIN is U24232TG2010PTC071273, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2010PTC071273 | Current |
| U24232AP2010PTC071273 | Previous |
Recognitions & Rankings of Elinor Pharmaceuticals
Contact details
Elinor Pharmaceuticals Private Limited's registered office is in Hyderabad, Andhra Pradesh. Its website is elinorpharma.wordpress.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address#2 – 4 – 602 Road No.9/A Behind Andhra Bank Nagole, Hyderabad, Andhra Pradesh, India – 500035
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Elinor Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Elinor Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Elinor Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Elinor Pharmaceuticals Private Limited, buy the company report.
Financials of Elinor Pharmaceuticals Private Limited
FY 2025 filings availableElinor Pharmaceuticals Private Limited reported revenue of ₹12.99 Cr (down 30% YoY) for FY 2024.
Revenue · FY 2024
₹12.99 Cr ▼ 30%
Net profit · FY 2024
₹33.24 Lakh margin 2.6%
EBITDA · FY 2024
₹74.99 Lakh margin 5.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 30%
3 years · compounded
▼ 5%
5 years · compounded
▼ 2%
EBITDA CAGR growth
1 year
▼ 16%
3 years · compounded
▼ 10%
5 years · compounded
▼ 6%
Revenue has declined at a compounded annual rate (CAGR) of 2% over five years, including a 30% fall in the latest year. EBITDA fell 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹74.99 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹33.24 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.8% | ||||
| Net Profit Margin | 2.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Elinor Pharmaceuticals Private Limited, buy the company report.
Board of directors of Elinor Pharmaceuticals Private Limited
Elinor Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gopala Krishna Konduru | Director | 29 Mar 2011 | 15 Years 6 Months | Current |
| Salla Santosh Also directs: Peakvive Health Solutions LLP | Director | 19 Nov 2010 | 15 Years 11 Months | Current |
Peer comparison
Elinor Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aurora Nutraceuticals Private Limited | ₹13.05 Cr (FY 2025) | -2.0% | New Delhi, Delhi, India | |||
| Novacel Therapeutics Private Limited | ₹13.03 Cr (FY 2020) | -27.0% | Guntur, Andhra Pradesh, India | |||
| Elinor Pharmaceuticals Private Limitedthis company | ₹12.99 Cr (FY 2024) | ₹33.24 Lakh | 2.6% | -30.0% | 89 | Hyderabad, Andhra Pradesh, India |
| Novolife Healthcare Private Limited | ₹12.98 Cr (FY 2025) | 10.0% | Hyderpora, Jammu and Kashmir, India | |||
| Good Hope Healthcare Private Limited | ₹12.97 Cr (FY 2025) | 3.0% | Chennai, Tamil Nadu, India | |||
| Maharaja Impex Private Limited | ₹12.96 Cr (FY 2025) | 406.0% | Chennai, Tamil Nadu, India | |||
| Legend Remedies Private Limited | ₹12.95 Cr (FY 2024) | 12.0% | Surat, Gujarat, India |
To see the full peer comparison of Elinor Pharmaceuticals Private Limited, buy the company report.
Auditor
Elinor Pharmaceuticals Private Limited is audited by K A R A & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K A R A & ASSOCIATES | FY 2022 | 013975S |
Shareholding
The shareholding of Elinor Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Elinor Pharmaceuticals Private Limited, buy the company report.
Legal cases
Elinor Pharmaceuticals Private Limited has 12 court cases on record: 12 filed by Elinor Pharmaceuticals. 9 cases are pending and 3 are disposed.
Total cases
12
Filed by the company
12
Pending
9
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 12 | 0 | 9 |
Cases on record (5 of 12)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad CCC, Telangana | Execution petition | Filed by the company against an individual | Pending |
| District court, Rangareddy, Telangana | Cheque dishonour complaint | Filed by the company against Sai Tirumala Enterprises and Represented by Its Proprietor Madduri Srinivasu | Pending |
| District court, Hyderabad CCC, Telangana | Civil suit | Filed by the company against an individual | Pending |
| District court, Rangareddy, Telangana | Cheque dishonour complaint | Filed by the company against Thasvik Pharma Distributors | Pending |
| District court, Rangareddy, Telangana | Cheque dishonour complaint | Filed by the company against Saanvi Pharma | Pending |
To see the full case history of Elinor Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Elinor Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Elinor Pharmaceuticals Private Limited has a workforce of 89 employees on its EPFO records as of Mar 23, 2024, across 1 active EPFO establishment.
Employee count
89
Active EPFO establishments
1
Employee growth
-29.92%
GST
Elinor Pharmaceuticals has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AACCE5699Q1ZP | Telangana | Active | 01 Jul 2017 |
| 37AACCE5699Q1ZN | Andhra Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Elinor Pharmaceuticals Private Limited, buy the company report.
Recent activity
Elinor Pharmaceuticals Private Limited has 4 board changes on record since 2010: 2 appointments and 2 cessations. The latest: Mahaboob Pasha Shaik ceased to be Director on 04 Aug 2020.
AGM
Elinor Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Elinor Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Mahaboob Pasha Shaik ceased to be Director.
Ceased
Puran Chand Mahankali ceased to be Director.
Appointed
Gopala Krishna Konduru was appointed as Director.
Appointed
Salla Santosh was appointed as Director.
Incorporation
19 Nov 2010
Elinor Pharmaceuticals Private Limited was registered on 19 Nov 2010 with Roc Hyderabad & aged 15 years 11 months as per MCA records.
Frequently asked questions
Elinor Pharmaceuticals is an active private limited company based in Hyderabad, Andhra Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 19 November 2010 (16+ years old) and is registered under CIN U24232TG2010PTC071273.
Elinor Pharmaceuticals has 2 current directors:
- Gopala Krishna Konduru - Director
- Salla Santosh - Director
The latest financial statements of Elinor Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Elinor Pharmaceuticals is 36AACCE5699Q1ZP, registered in Telangana. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 37AACCE5699Q1ZN (Andhra Pradesh).
The CIN (Corporate Identification Number) of Elinor Pharmaceuticals is U24232TG2010PTC071273. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Elinor Pharmaceuticals has 12 court cases on record: 12 filed by the company. 9 are pending.
Elinor Pharmaceuticals was incorporated on 19 November 2010, making it 16+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Elinor Pharmaceuticals by revenue are Aurora Nutraceuticals Private Limited, Novacel Therapeutics Private Limited, Novolife Healthcare Private Limited, Good Hope Healthcare Private Limited, Maharaja Impex Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Mahaboob Pasha Shaik ceased to be Director on 04 Aug 2020. Puran Chand Mahankali ceased to be Director on 07 Jul 2014. Gopala Krishna Konduru was appointed as Director on 29 Mar 2011. Elinor Pharmaceuticals has 4 board changes on record in total.
Yes, Elinor Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-TS-09-0008840).
Elinor Pharmaceuticals can be reached through the website elinorpharma.wordpress.com. Its registered office is in Hyderabad, Andhra Pradesh, India.